Tag archive for ‘MCUR’
Gali Weinreb On Sunday, August 3rd, 2014

3 Israeli biomed cos fall sharply after Nasdaq IPOs

– BioBlast’s share lost 38% of its value, Macrocure 25%, and VBL Therapeutics 18%. –   The shares of three Israeli biomedical companies that completed their IPOs last Wednesday More...

Jewish Business News On Thursday, July 31st, 2014

Israeli Macrocure raises $54 million in Nasdaq IPO

– The advanced cell therapy for chronic wound therapy company pricing of the shares at $10 was well below the $13-15 range that the company had planned. Regenerative medicine developer Macrocure Ltd. has More...

Wordpress site Developed by Fixing WordPress Problems